Revolutionizing Targeted Therapies with Logibody Technology

Advancing next-generation molecular therapeutics for a healthier future.
Learn More

About

Plectonic Biotech

Plectonic Biotech pioneers the next era of targeted therapeutics through its proprietary Logibody technology. With a foundation in DNA nanotechnology, our mission is to develop highly specific and effective molecular therapies that redefine precision medicine.

Learn More
Plectonic Biotech - About

Our Technology

Logibody molecules provide a novel approach to disease treatment by combining the specificity of antibody-based targeting with the enhanced stability and modularity of DNA nanostructures.

This cutting-edge innovation enables precision targeting of disease mechanisms with unmatched efficiency.

Learn More
Plectonic Biotech - Technology

Pipeline

Our development pipeline is focused on breakthrough therapies for oncology and autoimmune diseases. By leveraging our advanced molecular design, we aim to bring first-in-class therapeutics to clinical applications.

Learn More
Plectonic Biotech - Pipeline

Our Partners

We collaborate with leading research institutions, biotech firms, and pharmaceutical companies to accelerate the development of transformative therapeutics. Our commitment to innovation is strengthened through strategic partnerships that drive real-world impact.
  • Partner: SprinD
  • Partner: TUM
  • Partner: GO-Bio - BMBF
  • Partner: BioM
  • Partner: EIT Health EU

Join Our Team

At Plectonic Biotech, we seek visionary scientists, engineers, and business leaders to join our dynamic team. Together, we are pushing the boundaries of biotechnology to create life-changing therapies.
Apply Now